HB 2529
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill amends Pennsylvania’s Controlled Substance Act to include medetomidine in Schedule III. It defines criteria for Schedule III substances and outlines specific exceptions for medetomidine’s use in veterinary medicine, animal drug manufacturing, and pharmaceutical compounding. The bill also requires veterinarians to comply with secure storage regulations for medetomidine and xylazine, mirroring existing pharmacy storage requirements.
Key provisions
- Medetomidine is added to Schedule III of the Controlled Substance Act.
- The bill defines criteria for substances to be included in Schedule III.
- Exceptions are created for medetomidine use in veterinary medicine, animal drug manufacturing, and pharmaceutical compounding.
- Veterinarians must comply with secure storage regulations for medetomidine and xylazine.
- The act clarifies the use of medetomidine in non-human species for approved drugs.
- The act allows for the manufacturing and distribution of medetomidine as an active pharmaceutical ingredient for approved animal drugs.
Who is affected
- Veterinarians
- Pharmaceutical manufacturers
- Pharmacists
- Healthcare providers
- Animal owners
Notable changes
- Medetomidine is now classified as a Schedule III controlled substance.
- Specific exceptions are created for its use in veterinary medicine and animal drug manufacturing, expanding its permitted applications.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Benjamin Sanchez
G. Roni Green
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours